IPO Trending
MEDANTAEQ / NSE, BSEListed
Global Health

Global Health Limited is one of the largest private multi-speciality tertiary care providers in North and East India, operating under the "Medanta" brand. The company specializes in cardiology, neurosciences, oncology, digestive sciences, orthopaedics, liver transplants, and kidney care. With hospitals in Gurugram, Indore, Ranchi, and Lucknow, it offers healthcare services across 30 medical specialities with over 1,300 doctors and 2,467 installed beds. Medanta’s Gurugram hospital was ranked India’s best private hospital from 2020 to 2022 and featured in Newsweek’s global hospital rankings. The company emphasizes clinical research, academic excellence, and advanced medical infrastructure. Its strong financial performance, presence in high-demand areas, and expansion into digital health contribute to its growth. Backed by experienced management and institutional investors, Global Health Limited continues to strengthen its position in India's healthcare sector.

₹336 - ₹3369.58x sub
Listed Price₹401.00
Listing Gain+19.35%

Subscription Status

9.58xTotal Demand
Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date03 Nov 2022
Close Date07 Nov 2022
Listing Date16 Nov 2022
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Global Health IPO Subscription Demand

Live subscription status and bidding analysis for Global Health (MEDANTA) IPO. The issue is subscribed 9.58x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions